Clinicopathological significance of intratubular giant macrophages in progressive glomerulonephritis.
Very large macrophages, which we have termed "giant macrophages" (G-M phi), have been found in renal tubules, some containing cytoplasmic vacuoles. To elucidate their pathophysiological roles, we examined renal biopsy tissues from various primary glomerulonephritis (GN) and tubulointerstitial nephritis (TIN) using immunohistochemistry with monoclonal antibodies against M phi and other cell surface markers. Giant macrophages were absent or rare in TIN, minimal change nephrotic syndrome, and minor glomerular abnormalities, but G-M phi was plentiful in progressive glomerulonephrides such as IgA nephropathy with crescents, membranoproliferative GN, focal segmental glomerulosclerosis, and especially in crescentic GN. These G-M phi were usually seen in the lumen of renal tubules, but occasionally were found in the Bowman's spaces and glomerular tufts, and similar cells were also found in urine. Moreover, they frequently made contact with tubular epithelial cells expressing intercellular adhesion molecule-1, and the tubular epithelial cells in such lesions often had degenerative changes. Giant M phi may damage tubular epithelial cells from the luminal side. Phenotypically, G-M phi showed activated (CD71+) and mature (25F9+) characteristics along with features of M phi (CD68+), and the cytoplasm contained a great deal of lipids. The numbers of G-M phi in renal tissues closely correlated with the degree of hematuria (rho = 0.5, P < 0.001), serum creatinine value (r = 0.63, P < 0.001) in GN patients (N = 96) and with proteinuria in IgA nephropathy patients (r = 0.89, P < 0.001, N = 27). These data suggest that G-M phi are M phi that were activated and matured in certain active inflammatory sites, which flowed into tubules and then into urine. Thus, the existence of G-M phi in biopsy tissue or urine reflect the activity of GN and may have a predictive value for the progression of GN.
Oda
T
T
Department of Medicine, Japan Self Defense Forces Sendai Hospital, Japan.
Hotta
O
O
Taguma
Y
Y
Kitamura
H
H
Sugai
H
H
Onodera
S
S
Horigome
I
I
Suzuki
K
K
Shouji
Y
Y
Furuta
T
T
Chiba
S
S
Yoshizawa
N
N
Nagura
H
H
D000911:Antibodies, Monoclonal; D015726:Giant Cells / Q000276:immunology / Q000473:pathology*; D005921:Glomerulonephritis / Q000276:immunology / Q000473:pathology* / Q000652:urine; D005922:Glomerulonephritis, IGA / Q000276:immunology / Q000473:pathology; D015433:Glomerulonephritis, Membranous / Q000276:immunology / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D016130:Immunophenotyping; D007684:Kidney Tubules / Q000276:immunology / Q000473:pathology*; D008264:Macrophages / Q000276:immunology / Q000473:pathology*; D009395:Nephritis, Interstitial / Q000276:immunology / Q000473:pathology; D009402:Nephrosis, Lipoid / Q000276:immunology / Q000473:pathology; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism / Q000652:urine; D011971:Receptors, Immunologic / Q000235:genetics; D051116:Receptors, Scavenger; D014556:Urine / Q000166:cytology
D000911:Antibodies, Monoclonal; D012333:RNA, Messenger; D011971:Receptors, Immunologic; D051116:Receptors, Scavenger